Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VMT-01: Vaginal Microbiota Transplant for Bacterial Vaginosis
NCT03769688Phase 1Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Mar 2022
- Primary completion
- Dec 2023
01
Overview
Phase 1, randomised, double-blind trial in bacterial vaginosis (BV) (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Bacteria engraftment as assessed by ribosomal (rDNA) gene sequencing at 28 days. Planned start Mar 2022; status: withdrawn.
02
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT03769688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03769688.